Eterna Therapeutics Inc. (ERNA)
0.20
0.02 (8.17%)
At close: Apr 02, 2025, 3:57 PM
0.20
0.05%
After-hours: Apr 02, 2025, 07:28 PM EDT
Eterna Therapeutics Balance Sheet Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
| Cash & Equivalents | 1.73M | 7.58M | 11.45M | 16.98M | 1.63M | 3.26M | 2.59M | 3.38M | 5.69M | 3.22M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | 4.09M | 59K | 1M | -449K | 150K | 200K | 1.09M | 999K | 1.02M |
| Other Long-Term Assets | 118K | 120K | 5.23M | 522K | 453K | 2.29M | 527K | 791K | 984K | 1.45M |
| Receivables | 437K | 425K | 951K | 684K | n/a | 1.2M | 1.14M | 714K | 928K | 919K |
| Inventory | n/a | n/a | -951K | n/a | n/a | 1.09M | 2.54M | 4.87M | 3M | n/a |
| Other Current Assets | 186K | 1.6M | n/a | 1.1M | n/a | 526K | 517K | 680K | 1.05M | 4.97M |
| Total Current Assets | 2.35M | 9.6M | 13.68M | 18.77M | 1.73M | 6.07M | 6.79M | 9.64M | 10.66M | 9.11M |
| Property-Plant & Equipment | 755K | 33.27M | 1.27M | 3.24M | 2.69M | 4.92M | 4.67M | 3.68M | 3.1M | 3.92M |
| Goodwill & Intangibles | 2.04M | 2.04M | 2.04M | 8.9M | 8.03M | 696K | 667K | 1M | 937K | 909K |
| Total Long-Term Assets | 2.92M | 39.53M | 8.6M | 13.66M | 11.17M | 9.21M | 8.08M | 6.93M | 6.47M | 7.71M |
| Total Assets | 5.27M | 49.13M | 22.28M | 32.43M | 12.91M | 15.28M | 14.86M | 16.57M | 17.14M | 16.82M |
| Account Payables | 1.72M | 1.07M | 1.62M | 1.75M | 1.27M | 835K | 271K | 390K | 247K | 211K |
| Deferred Revenue | n/a | 190K | n/a | 1.25M | 76K | 460K | 1.37M | 3.56M | 1.06M | 1.21M |
| Short-Term Debt | 207K | 2.22M | 1.75M | 426K | 526K | 3.17M | 1.04M | 5.24M | 3.14M | 1.15M |
| Other Current Liabilities | 15K | 773K | 2.92M | 477K | 672K | 1.63M | 1.34M | 1.56M | 2.19M | 2.55M |
| Total Current Liabilities | 2.94M | 6.57M | 7.65M | 3.68M | 3.13M | 6.09M | 4.02M | 10.75M | 6.64M | 5.12M |
| Long-Term Debt | 477K | 6.77M | 2.09M | n/a | 194K | 2.91M | 2.73M | 8K | 5.12M | 6.37M |
| Other Long-Term Liabilities | 153K | 307K | -462K | 19.95M | 23K | -2.87M | 1.08M | -208K | 383K | 541K |
| Total Long-Term Liabilities | 630K | 40.33M | 2.52M | 22.25M | 2.12M | 4.09M | 3.92M | 287K | 6.42M | 7.85M |
| Total Liabilities | 3.57M | 46.9M | 10.17M | 25.93M | 5.25M | 10.19M | 7.95M | 11.03M | 13.07M | 12.97M |
| Total Debt | 684K | 41.84M | 4.14M | 2.72M | 2.9M | 6.08M | 3.81M | 5.41M | 8.53M | 7.65M |
| Common Stock | 257K | 27K | 26K | 260K | 25.8M | 14K | 14K | 13K | 11K | 462K |
| Retained Earnings | -231.54M | -186.98M | -165.3M | -159.7M | -18.14M | -131.46M | -129.39M | -129.12M | -128.03M | -125.09M |
| Comprehensive Income | n/a | n/a | n/a | n/a | 245K | 268K | 200K | 345K | 223K | 172K |
| Shareholders Equity | 1.7M | 2.23M | 12.11M | 6.5M | 7.66M | 5.09M | 6.92M | 5.54M | 4.07M | 3.85M |
| Total Investments | n/a | 4.09M | 59K | 1M | -449K | 150K | 200K | 1.09M | 999K | 1.02M |